The estimated Net Worth of Enterprise Associates 14, L... is at least $17.3 Million dollars as of 5 April 2022. Enterprise L owns over 694,551 units of Imara Inc stock worth over $16,501,836 and over the last 3 years Enterprise sold IMRA stock worth over $750,115.
Enterprise has made over 1 trades of the Imara Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Enterprise sold 694,551 units of IMRA stock worth $750,115 on 5 April 2022.
The largest trade Enterprise's ever made was selling 694,551 units of Imara Inc stock on 5 April 2022 worth over $750,115. On average, Enterprise trades about 694,551 units every 0 days since 2022. As of 5 April 2022 Enterprise still owns at least 2,611,050 units of Imara Inc stock.
You can see the complete history of Enterprise L stock trades at the bottom of the page.
Over the last 5 years, insiders at Imara Inc have traded over $7,889,059 worth of Imara Inc stock and bought 11,496,717 units worth $107,874,489 . The most active insiders traders include David M Mott, Lundbeck A S H, and Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of $1,965,179. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth $46,028.
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.
Imara Inc executives and other stock owners filed with the SEC include: